| UNITED STATES SURGICAL CORPORATION AND
SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS
|
|||||
In thousands, except per share data |
Years Ended December 31, | ||||
|---|---|---|---|---|---|
| 1996 | 1995 | 1994 | |||
| Net Sales | $1,112,700 | $1,022,300 | $918,700 | ||
| Costs and expenses: | |||||
| Cost of products sold | 460,600 | 451,700 | 463,600 | ||
| Research and development | 58,000 | 43,100 | 37,500 | ||
| Selling, general and administrative | 443,400 | 417,000 | 366,700 | ||
| Interest (net) | 9,000 | 20,700 | 18,200 | ||
| Total costs and expenses | 971,000 | 932,500 | 886,000 | ||
| Income before income taxes | 141,700 |
89,800 |
32,700 |
||
| Income taxes | 32,600 |
10,600 |
13,500 |
||
| Net income | 109,100 |
79,200 |
19,200 |
||
| Preferred stock dividends | 19,500 |
19,500 |
14,900 |
||
| Net income applicable to common stock |
$89,600 |
$59,700 |
$4,300 |
||
Average number of common shares outstanding |
60,500 |
57,000 |
56,600 |
||
Net income per common share (primary and fully diluted) |
$1.48 |
$1.05 |
$.08 |
||
Dividends paid per common share |
$.08 |
$.08 |
$.08 |
||
Trademarks of United States Surgical Corporation and its subsidiaries throughout this publication are italicized.
Copyright © 1997 United States Surgical Corporation. All Rights Reserved.
Contact webteam